The Effect of Vasopressor on Pressure Injury Development
Status:
Completed
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Background: Vasopressors are life-saving agents that increase mean arterial pressure. The
pharmacodynamic features of these agents and previous studies suggest that vasopressors may
be an essential risk factor in developing pressure injuries.
Objective: This study aimed to examine the effect of vasopressors in medical-surgical
intensive care patients on pressure injury development.
Design and Settings: This retrospective and correlational study was conducted between March
2021- May 2022. The electronic patient data were obtained from 148 surgical and medical
patients treated with vasopressor agents in the intensive care unit. Data on patients'
demographic and clinical characteristics were evaluated using descriptive statistical methods
(number, percentage, mean, standard deviation). A logistic regression model was established
to estimate the dependent variable (development of pressure injury) with the independent
variables.